BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
0.824
-0.024 (-2.85%)
At close: Dec 5, 2025, 4:00 PM EST
0.850
+0.026 (3.17%)
After-hours: Dec 5, 2025, 7:49 PM EST
BioAtla Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | - | 11 | - | - | 0.25 | 0.43 | |
| Revenue Growth (YoY) | - | - | - | - | -41.73% | -91.75% | |
| Cost of Revenue | 46.73 | 63.1 | 103.73 | 79.35 | 58.27 | 19.93 | |
| Gross Profit | -46.73 | -52.1 | -103.73 | -79.35 | -58.02 | -19.5 | |
| Selling, General & Admin | 18.97 | 21.85 | 25.96 | 28.79 | 38.42 | 10.6 | |
| Operating Expenses | 18.97 | 21.85 | 25.96 | 28.79 | 38.42 | 10.6 | |
| Operating Income | -65.69 | -73.94 | -129.69 | -108.14 | -96.44 | -30.1 | |
| Interest Expense | - | - | - | - | -0 | -1.39 | |
| Interest & Investment Income | 1.32 | 3.37 | 6.31 | 1.65 | 0.35 | 0.1 | |
| Other Non Operating Income (Expenses) | 0.26 | 0.8 | -0.09 | 0.01 | 0 | -1.58 | |
| EBT Excluding Unusual Items | -64.11 | -69.78 | -123.46 | -106.48 | -96.09 | -32.97 | |
| Other Unusual Items | - | - | - | - | 0.69 | -2.88 | |
| Pretax Income | -64.71 | -69.78 | -123.46 | -106.48 | -95.4 | -35.85 | |
| Earnings From Continuing Operations | -64.71 | -69.78 | -123.46 | -106.48 | -95.4 | -35.85 | |
| Net Income | -64.71 | -69.78 | -123.46 | -106.48 | -95.4 | -35.85 | |
| Preferred Dividends & Other Adjustments | - | - | - | - | - | -8.98 | |
| Net Income to Common | -64.71 | -69.78 | -123.46 | -106.48 | -95.4 | -26.88 | |
| Shares Outstanding (Basic) | 56 | 49 | 48 | 39 | 35 | 8 | |
| Shares Outstanding (Diluted) | 56 | 49 | 48 | 39 | 35 | 8 | |
| Shares Change (YoY) | 16.89% | 1.67% | 22.73% | 12.63% | 310.07% | -84.56% | |
| EPS (Basic) | -1.15 | -1.44 | -2.58 | -2.74 | -2.76 | -3.19 | |
| EPS (Diluted) | -1.15 | -1.44 | -2.58 | -2.74 | -2.76 | -3.19 | |
| Free Cash Flow | -57.07 | -71.94 | -104.11 | -90.69 | -63.14 | -36.92 | |
| Free Cash Flow Per Share | -1.01 | -1.48 | -2.18 | -2.33 | -1.83 | -4.38 | |
| Operating Margin | - | -672.21% | - | - | -38576.00% | -7016.08% | |
| Profit Margin | - | -634.33% | - | - | -38160.80% | -6265.03% | |
| Free Cash Flow Margin | - | -653.96% | - | - | -25255.20% | -8606.99% | |
| EBITDA | -65.11 | -73.02 | -128.47 | -106.94 | -95.11 | -29.09 | |
| D&A For EBITDA | 0.58 | 0.93 | 1.22 | 1.2 | 1.33 | 1.01 | |
| EBIT | -65.69 | -73.94 | -129.69 | -108.14 | -96.44 | -30.1 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.